Feb 23 (Reuters) - Avita Medical Inc RCEL.O :
* AVITA MEDICAL REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL RESULTS AND PROVIDES 2023 FINANCIAL GUIDANCE
* COMMERCIAL REVENUE, WHICH EXCLUDES BARDA REVENUE, FOR FULL
YEAR
2023 IS EXPECTED TO BE IN RANGE OF $49 TO $51 MILLION
* COMMERCIAL REVENUE, WHICH EXCLUDES BARDA REVENUE, FOR Q1
2023 IS
EXPECTED TO BE IN RANGE OF $10 TO $11 MILLION
* QTRLY LOSS PER SHARE OF $0.21
* Q4 EARNINGS PER SHARE VIEW $-0.29, REVENUE VIEW $8.7
MILLION --
REFINITIV IBES DATA
* TOTAL REVENUE INCREASED BY 36% TO $9.5 MILLION COMPARED TO
$6.9
MILLION IN SAME PERIOD IN 2021
Source text for Eikon: ID:nGNX73T9t0
Further company coverage: RCEL.O
((Reuters.Briefs@thomsonreuters.com;))